Ad is loading...
SUVAX
Price
$14.38
Change
+$0.17 (+1.20%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

SUVAX vs VVIAX

Header iconSUVAX vs VVIAX Comparison
Open Charts SUVAX vs VVIAXBanner chart's image
PGIM Quant Solutions Large-Cap Val A
Price$14.38
Change+$0.17 (+1.20%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
SUVAX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SUVAX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUVAX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. SUVAX (268M). VVIAX pays higher dividends than SUVAX: VVIAX (2.36) vs SUVAX (0.90). SUVAX was incepted earlier than VVIAX: SUVAX (24 years) vs VVIAX (24 years). SUVAX is a more actively managed with annual turnover of: 96.00 vs. VVIAX (10.00). SUVAX has a lower initial minimum investment than VVIAX: SUVAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. SUVAX (22.80). VVIAX return over 5 years is better than : 53.09 vs. SUVAX (19.80).
SUVAXVVIAXSUVAX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years24 years-
Gain YTD16.62619.67285%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets268M184B0%
Annual Yield % from dividends0.902.3638%
Returns for 1 year22.8026.0987%
Returns for 3 years-0.7324.77-3%
Returns for 5 years19.8053.0937%
Returns for 10 years0.76112.261%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics